Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00109746 · ClinicalTrials.gov registry record · Phase 1
Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT00109746 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 39 participants.
The verdict
NCT00109746, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of the nutritional supplement chromium picolinate in improving insulin resistance, a symptom of diabetes, in HIV-infected patients. The ultimate goal is to find a simple therapy that can prevent the development of diabetes in individuals with HIV.
Interventions
- DIETARY_SUPPLEMENT chromium picolinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2005-11 |
| Est. Completion | 2010-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00109746
The ClinicalTrials.gov registry entry for NCT00109746 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which chromium picolinate is the first listed.
NCT00109746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00109746 about?
NCT00109746 is a clinical study titled "Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults". The purpose of this study is to determine the effectiveness of the nutritional supplement chromium picolinate in improving insulin resistance, a symptom of diabetes, in HIV-infected patients. The ultimate goal is to find a simple therapy that can prevent the development of diabetes in individuals wi...
What is the current status of trial NCT00109746?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2005-11. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00109746?
The interventions under investigation include: chromium picolinate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00109746?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.